APA (7th ed.) Citation

MS, R., YD, M., S, V., S, G., E, S., P, M. V., . . . C, P. P. (2025). FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression. International journal of cancer, 156(10), 2024. https://doi.org/10.1002/ijc.35302

Chicago Style (17th ed.) Citation

MS, Rodriguez, et al. "FGFR2-RUNX2 Activation: An Unexplored Therapeutic Pathway in Luminal Breast Cancer Related to Tumor Progression." International Journal of Cancer 156, no. 10 (2025): 2024. https://doi.org/10.1002/ijc.35302.

MLA (9th ed.) Citation

MS, Rodriguez, et al. "FGFR2-RUNX2 Activation: An Unexplored Therapeutic Pathway in Luminal Breast Cancer Related to Tumor Progression." International Journal of Cancer, vol. 156, no. 10, 2025, p. 2024, https://doi.org/10.1002/ijc.35302.